ALHC:NSD-Alignment Healthcare LLC (USD)

COMMON STOCK | Healthcare Plans | NSD

Last Closing Price

USD 12.61

Change

+0.25 (+2.02)%

Market Cap

USD 2.31B

Volume

0.46M

Avg Analyst Target

USD 19.33 (+53.32%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ALHC Stock Forecast & Price:
Based on the Alignment Healthcare LLC stock forecasts from 7 analysts, the average analyst target price for Alignment Healthcare LLC is USD 19.33 over the next 12 months. Alignment Healthcare LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alignment Healthcare LLC is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Alignment Healthcare LLC’s stock price was USD 12.61. Alignment Healthcare LLC’s stock price has changed by +8.89% over the past week, -3.00% over the past month and -24.13% over the last year.

About Alignment Healthcare LLC (ALHC:NSD)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantag ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-11-29 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MGLN Magellan Health Inc

N/A

USD2.50B 8.49 16.66
CLOV Clover Health Investments Corp

+0.01 (+0.82%)

USD0.63B N/A 0.22
BFYT Benefytt Technologies, Inc

N/A

USD0.44B 8.82 132.97
MRAI Marpai Inc

+0.04 (+4.39%)

USD0.02B N/A -0.97

ETFs Containing ALHC

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Healthcare Plans)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.31% 100% A+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.31% 100% A+ 62% D-
Trailing 12 Months  
Capital Gain -22.21% 100% A+ 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.21% 100% A+ 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -16.05% 67% D+ 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.05% 67% D+ 20% F
Risk Return Profile  
Volatility (Standard Deviation) 21.86% 67% D+ 67% D+
Risk Adjusted Return -73.43% 67% D+ 12% F
Market Capitalization 2.31B 100% A+ 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Healthcare Plans)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 8.30 33% F 10% F
Price / Cash Flow Ratio -29.38 100% A+ 78% C+
EV/EBITDA -17.60 100% A+ 86% B
Management Effectiveness  
Return on Equity -47.04% 100% A+ 31% F
Return on Invested Capital -56.40% 100% A+ 22% F
Return on Assets -10.46% 100% A+ 35% F
Debt to Equity Ratio 49.21% 50% F 38% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.00 33% F 37% F
Short Percent 3.28% 67% D+ 41% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.